PARIS – A major new deal has been concluded in the world of med-techs. Stryker Corp. of Kalamazoo, Mich., has just made a tender offer for Balma, France-based Vexim SA. The U.S. orthopedics giant paid $215.7 million to acquire this French company specializing in minimally invasive treatment of vertebral fractures, which has been listed on the Euronext Growth market since 2012. "This integration will help us speed up international development of our technology for repairing vertebral fractures and consolidate our position in Europe," Vincent Gardès, CEO of Vexim, told BioWorld MedTech.